| Family: | Vanguard |
| Name: | Vanguard Health Care ETF |
| Inception Date: | 26-Jan-2004 |
| Termination Date: | |
| Investment Objective: | Seeks to track the performance of a benchmark index that measures the investment return of stocks in the health care sector. Passively managed using a full-replication strategy when possible and a sampling strategy if regulatory constraints dictate. Includes stocks of companies involved in providing medical or health care products services technology or equipment. |
| Prospectus | |
| Top 10 Holdings | ||
| Eli Lilly & Co | LLY | 14.1600% |
| Johnson & Johnson | JNJ | 8.8681% |
| AbbVie Inc | ABBV | 6.5429% |
| UnitedHealth Group Inc | UNH | 5.5457% |
| Merck & Co Inc | MRK | 4.6702% |
| Amgen Inc | AMGN | 2.8696% |
| Thermo Fisher Scientific Inc | TMO | 2.7390% |
| Abbott Laboratories | ABT | 2.3232% |
| Gilead Sciences Inc | GILD | 2.3052% |
| Intuitive Surgical Inc | ISRG | 2.0763% |
| Top 10 Holdings Weight: | 52.1% |
| Number of Holdings: | 428 |
| Shares Outstanding: | 59,849,952 |
| Total Net Assets: | 18,153,090,000 |
| NAV: | 303.39 |
| Net Expense Ratio: | 0.09% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Developed Market Funds |
| Country: | US |
| Region: | |
| Strategy: | |
| Currency: | |
| Commodity: | |
| Sector: | Healthcare |
| Industry: | |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Broad Market / Multi-Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | |
| Is Currency Hedged: | No |
| US or Ex-US: | Domestic |
